COVID-19 Impact on Global Long-acting Injectable Medications Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

1 Market Overview of Long-acting Injectable Medications

• 1.1 Long-acting Injectable Medications Market Overview
  • 1.1.1 Long-acting Injectable Medications Product Scope
  • 1.1.2 Market Status and Outlook
• 1.2 Global Long-acting Injectable Medications Market Size Overview by Region 2015 VS 2020 VS 2026
• 1.3 Global Long-acting Injectable Medications Market Size by Region (2015-2026)
• 1.4 Global Long-acting Injectable Medications Historic Market Size by Region (2015-2020)
• 1.5 Global Long-acting Injectable Medications Market Size Forecast by Region (2021-2026)
• 1.6 Key Regions, Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
  • 1.6.1 North America Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
  • 1.6.2 Europe Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
  • 1.6.3 Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
  • 1.6.4 Latin America Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
  • 1.6.5 Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2015-2026)

2 Long-acting Injectable Medications Market Overview by Type

• 2.1 Global Long-acting Injectable Medications Market Size by Type: 2015 VS 2020 VS 2026
• 2.2 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
• 2.3 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)
• 2.4 First-generation
• 2.5 Second-generation

3 Long-acting Injectable Medications Market Overview by Application

• 3.1 Global Long-acting Injectable Medications Market Size by Application: 2015 VS 2020 VS 2026
• 3.2 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
• 3.3 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)
• 3.4 Schizophrenia
• 3.5 Contraception
• 3.6 HIV
• 3.7 Others

4 Global Long-acting Injectable Medications Competition Analysis by Players

• 4.1 Global Long-acting Injectable Medications Market Size by Players (2015-2020)
• 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2019)
• 4.3 Date of Key Manufacturers Enter into Long-acting Injectable Medications Market
• 4.4 Global Top Players Long-acting Injectable Medications Headquarters and Area Served
• 4.5 Key Players Long-acting Injectable Medications Product Solution and Service
• 4.6 Competitive Status
  • 4.6.1 Long-acting Injectable Medications Market Concentration Rate
  • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

• 5.1 Eli Lilly
  • 5.1.1 Eli Lilly Profile
  • 5.1.2 Eli Lilly Main Business
  • 5.1.3 Eli Lilly Long-acting Injectable Medications Products, Services and Solutions
  • 5.1.4 Eli Lilly Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.1.5 Eli Lilly Recent Developments
• 5.2 Alkermes
  • 5.2.1 Alkermes Profile
  • 5.2.2 Alkermes Main Business
  • 5.2.3 Alkermes Long-acting Injectable Medications Products, Services and Solutions
  • 5.2.4 Alkermes Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.2.5 Alkermes Recent Developments
• 5.3 Johnson & Johnson
  • 5.5.1 Johnson & Johnson Profile
  • 5.3.2 Johnson & Johnson Main Business
  • 5.3.3 Johnson & Johnson Long-acting Injectable Medications Products, Services and Solutions
  • 5.3.4 Johnson & Johnson Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.3.5 Zogenix Recent Developments
• 5.4 Zogenix
  • 5.4.1 Zogenix Profile
  • 5.4.2 Zogenix Main Business
  • 5.4.3 Zogenix Long-acting Injectable Medications Products, Services and Solutions
  • 5.4.4 Zogenix Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.4.5 Zogenix Recent Developments
• 5.5 DURECT
  • 5.5.1 DURECT Profile
  • 5.5.2 DURECT Main Business
  • 5.5.3 DURECT Long-acting Injectable Medications Products, Services and Solutions
  • 5.5.4 DURECT Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.5.5 DURECT Recent Developments
• 5.6 Mapi Pharma
  • 5.6.1 Mapi Pharma Profile
  • 5.6.2 Mapi Pharma Main Business
  • 5.6.3 Mapi Pharma Long-acting Injectable Medications Products, Services and Solutions
  • 5.6.4 Mapi Pharma Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.6.5 Mapi Pharma Recent Developments
• 5.7 GSK
  • 5.7.1 GSK Profile
  • 5.7.2 GSK Main Business
  • 5.7.3 GSK Long-acting Injectable Medications Products, Services and Solutions
  • 5.7.4 GSK Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.7.5 GSK Recent Developments
• 5.8 MedinCell
  • 5.8.1 MedinCell Profile
  • 5.8.2 MedinCell Main Business
  • 5.8.3 MedinCell Long-acting Injectable Medications Products, Services and Solutions
  • 5.8.4 MedinCell Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.8.5 MedinCell Recent Developments
• 5.9 Oakwood Labs
  • 5.9.1 Oakwood Labs Profile
  • 5.9.2 Oakwood Labs Main Business
  • 5.9.3 Oakwood Labs Long-acting Injectable Medications Products, Services and Solutions
  • 5.9.4 Oakwood Labs Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.9.5 Oakwood Labs Recent Developments
• 5.10 Nanomi
  • 5.10.1 Nanomi Profile
  • 5.10.2 Nanomi Main Business
  • 5.10.3 Nanomi Long-acting Injectable Medications Products, Services and Solutions
  • 5.10.4 Nanomi Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.10.5 Nanomi Recent Developments
• 5.11 Pharmathen
  • 5.11.1 Pharmathen Profile
  • 5.11.2 Pharmathen Main Business
  • 5.11.3 Pharmathen Long-acting Injectable Medications Products, Services and Solutions
  • 5.11.4 Pharmathen Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.11.5 Pharmathen Recent Developments
• 5.12 Kashiv BioSciences
  • 5.12.1 Kashiv BioSciences Profile
  • 5.12.2 Kashiv BioSciences Main Business
  • 5.12.3 Kashiv BioSciences Long-acting Injectable Medications Products, Services and Solutions
  • 5.12.4 Kashiv BioSciences Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
  • 5.12.5 Kashiv BioSciences Recent Developments

6 North America

• 6.1 North America Long-acting Injectable Medications Market Size by Country
• 6.2 United States
• 6.3 Canada

7 Europe

• 7.1 Europe Long-acting Injectable Medications Market Size by Country
• 7.2 Germany
• 7.3 France
• 7.4 U.K.
• 7.5 Italy
• 7.6 Russia
• 7.7 Nordic
• 7.8 Rest of Europe

8 Asia-Pacific

• 8.1 Asia-Pacific Long-acting Injectable Medications Market Size by Region
• 8.2 China
• 8.3 Japan
• 8.4 South Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australia
• 8.8 Rest of Asia-Pacific

9 Latin America

• 9.1 Latin America Long-acting Injectable Medications Market Size by Country
• 9.2 Mexico
• 9.3 Brazil
• 9.4 Rest of Latin America

10 Middle East & Africa

• 10.1 Middle East & Africa Long-acting Injectable Medications Market Size by Country
• 10.2 Turkey
• 10.3 Saudi Arabia
• 10.4 UAE
• 10.5 Rest of Middle East & Africa

11 Long-acting Injectable Medications Market Dynamics

• 11.1 Industry Trends
• 11.2 Market Drivers
• 11.3 Market Challenges
• 11.4 Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Disclaimer